NCT03574402 2022-12-06
TRUMP
Guangdong Association of Clinical Trials
Phase 2 Unknown
Clinical Trials
6 trialsNCT02330367 2021-09-10
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 1/2 Unknown
NCT03856697 2019-02-27
Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 3 Unknown
NCT03300115 2019-02-19
Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 2 Unknown
NCT03060850 2019-02-01
A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Phase 1 Unknown
NCT02274337 2016-11-23
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer
Sun Yat-sen University
Phase 1/2 Unknown